Antipsychotic drugs may increase the risk of death in people with Parkinson's disease psychosis (PDP), according to a new study led by researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London.
Increased serotonergic fibre innervation relative to dopaminergic fibre availability may be a potential marker of disease progression in Parkinson’s disease patients and a possible warning of levodopa-induced dyskinesia, indicates an in vivo...
This was a randomized, double-blind, placebo-controlled, parallel-group study of 83 PD patients with troublesome dyskinesia assigned to placebo or one of three doses of ADS-5102 (260 mg, 340 mg, 420 mg) administered daily at bedtime for 8 weeks.
The 5-HT (5-hydroxytryptamine) system has a key role in the development of 3,4-dihydroxyphenyl-l-alanine (l-DOPA)-induced dyskinesia, mainly due to 5-HT neuronal ability to decarboxylate l-DOPA into dopamine. The present work indicates that potential l-DOPA-induced deterioration of 5-HT function might reduce l-DOPA efficacy as well as promote the occurrence of motor side effects.
Dr. Mark A. Varney, PhD., will present at the forthcoming 8th Neurodegenerative Conditions Research & Development meeting to be held September 18-19, 2014 in San Francisco, CA. Dr. Varney has been invited to present in the session on Drug Mechanisms & Treatments in Parkinson's Disease.
Neurolixis Showcased in The Michael J. Fox Foundation’s Partnering Program. Neurolixis today announced that it had been selected by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to be showcased in its Partnering Program.
Depressive symptoms are very common in patients with Parkinson’s disease and have a significant impact on the quality of life. The results of this study show that in patients with PD, higher l-DOPA dosages correlate with worse depressive symptoms.
Acorda today agreed to pay $525 million in cash to acquire Civitas, the Chelsea, MA-based company developing an inhalable version of the decades-old Parkinson’s drug, levodopa (or L-dopa), called CVT-301. ...
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.